DK0736039T3 - Forbindelser med væksthormon-frigivende egenskaber - Google Patents

Forbindelser med væksthormon-frigivende egenskaber

Info

Publication number: DK0736039T3
Authority: DK; Denmark
Prior art keywords: growth hormone; compounds; pct; releasing properties; date jun
Prior art date: 1993-12-23

Application number

DK95903774T

Other languages

English (en)

Inventor

Nils Langeland Johansen

Behrend Friedrich Lundt

Jesper Lau

Kjeld Madsen

Gersen Henning Th

Birgit Sehested Hansen

Bernd Peschke

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-23

Filing date

1994-12-22

Publication date

2001-02-12

1993-12-23 Priority claimed from DK143993A external-priority patent/DK143993D0/da

1994-12-22 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2001-02-12 Application granted granted Critical

2001-02-12 Publication of DK0736039T3 publication Critical patent/DK0736039T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK95903774T 1993-12-23 1994-12-22 Forbindelser med væksthormon-frigivende egenskaber DK0736039T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK143993A DK143993D0 (da)	1993-12-23	1993-12-23
DK12194		1994-01-28
DK119194		1994-10-14
PCT/DK1994/000485 WO1995017423A1 (en)	1993-12-23	1994-12-22	Compounds with growth hormone releasing properties

Publications (1)

Publication Number	Publication Date
DK0736039T3 true DK0736039T3 (da)	2001-02-12

Family

ID=27220421

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95903774T DK0736039T3 (da)	1993-12-23	1994-12-22	Forbindelser med væksthormon-frigivende egenskaber

Country Status (27)

Country	Link
US (1)	US5767085A (da)
EP (1)	EP0736039B1 (da)
JP (1)	JP3181918B2 (da)
KR (1)	KR100354897B1 (da)
CN (1)	CN1052731C (da)
AT (1)	ATE197158T1 (da)
AU (1)	AU689181B2 (da)
BR (1)	BR9408377A (da)
CA (1)	CA2179597A1 (da)
CZ (1)	CZ293113B6 (da)
DE (1)	DE69426206T2 (da)
DK (1)	DK0736039T3 (da)
ES (1)	ES2153469T3 (da)
FI (1)	FI962584A0 (da)
GR (1)	GR3035150T3 (da)
HU (1)	HU224345B1 (da)
IL (1)	IL112112A (da)
MX (1)	MX9500072A (da)
NO (1)	NO315561B1 (da)
NZ (1)	NZ277486A (da)
PL (1)	PL181280B1 (da)
PT (1)	PT736039E (da)
RO (1)	RO115635B1 (da)
SG (1)	SG55069A1 (da)
SK (1)	SK281963B6 (da)
UA (1)	UA42747C2 (da)
WO (1)	WO1995017423A1 (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995014666A1 (en) *	1993-11-24	1995-06-01	Merck & Co., Inc.	Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
US5854211A (en) *	1993-12-23	1998-12-29	Novo Nordisk A/S	Compounds with growth hormone releasing properties
US20020111461A1 (en) *	1999-05-21	2002-08-15	Todd C. Somers	Low molecular weight peptidomimetic growth hormone secretagogues
US5798337A (en) *	1994-11-16	1998-08-25	Genentech, Inc.	Low molecular weight peptidomimetic growth hormone secretagogues
MY113488A (en) *	1995-01-27	2002-03-30	Novo Nordisk As	Compounds with growth hormone releasing properties
HUP9802821A3 (en) *	1995-06-22	2000-03-28	Novo Nordisk As	Compounds with growth hormone releasing properties
WO1997022004A1 (en)	1995-12-13	1997-06-19	Merck & Co., Inc.	Assays for growth hormone secretagogue receptors
US6531314B1 (en)	1996-12-10	2003-03-11	Merck & Co., Inc.	Growth hormone secretagogue receptor family
GB2308362A (en) *	1995-12-19	1997-06-25	Lilly Industries Ltd	Pharmaceutical indole derivatives
AU715856B2 (en) *	1995-12-22	2000-02-10	Novo Nordisk A/S	Compounds with growth hormone releasing properties
US6451970B1 (en)	1996-02-21	2002-09-17	Novo Nordisk A/S	Peptide derivatives
US5919777A (en) *	1996-04-24	1999-07-06	Novo Nordisk A/S	Compounds with growth hormone releasing properties
WO1997040023A1 (en) *	1996-04-24	1997-10-30	Novo Nordisk A/S	Compounds with growth hormone releasing properties
EP1184370B1 (en) *	1996-07-22	2005-09-14	Novo Nordisk A/S	Compounds with growth hormone releasing properties
AU3938797A (en) *	1996-08-29	1998-03-19	Novo Nordisk A/S	Transdermal delivery of peptides
US6121416A (en) *	1997-04-04	2000-09-19	Genentech, Inc.	Insulin-like growth factor agonist molecules
US6420518B1 (en)	1997-04-04	2002-07-16	Genetech, Inc.	Insulin-like growth factor agonist molecules
WO1998058950A1 (en)	1997-06-20	1998-12-30	Novo Nordisk A/S	Compounds with growth hormone releasing properties
US6127341A (en) *	1997-06-20	2000-10-03	Novo Nordisk A/S	Compounds with growth hormone releasing properties
IL137007A0 (en)	1998-01-16	2001-06-14	Novo Nordisk As	Compounds with growth hormone releasing properties
US6919315B1 (en)	1998-06-30	2005-07-19	Novo Nordisk A/S	Compounds with growth hormone releasing properties
US6682908B1 (en)	1998-07-10	2004-01-27	Merck & Co., Inc.	Mouse growth hormone secretagogue receptor
WO2000002919A1 (en)	1998-07-13	2000-01-20	Merck & Co., Inc.	Growth hormone secretagogue related receptors and nucleic acids
JP2002522058A (ja)	1998-08-10	2002-07-23	メルク・アンド・カンパニー・インコーポレーテッド	イヌ成長ホルモン分泌促進物質受容体
US6696063B1 (en) *	1998-12-30	2004-02-24	Applied Research Systems Ars Holding N.V.	Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
AU762351B2 (en)	1999-01-06	2003-06-26	Genentech Inc.	Insulin-like growth factor (IGF) I mutant variants
KR100699404B1 (ko)	1999-02-18	2007-03-23	가켄 세야쿠 가부시키가이샤	성장 호르몬 분비촉진제로서의 신규 아미드 유도체
EP1200111A1 (en) *	1999-06-04	2002-05-02	Novo Nordisk A/S	Compositions for the treatment of the catabolic state of prolonged critical illness
AU2001263215A1 (en)	2000-05-16	2001-11-26	Genentech Inc.	Method for treating cartilage disorders
ATE446758T1 (de)	2000-05-31	2009-11-15	Pfizer Prod Inc	Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
TWI331922B (en)	2002-08-09	2010-10-21	Ipsen Pharma Sas	Growth hormone releasing peptides
JP2007513065A (ja) *	2003-05-19	2007-05-24	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	粒径が制御された酸化チタンを含むハードゼラチンカプセルおよびそれを製造する方法
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
DK2274978T3 (da)	2003-09-12	2015-06-15	Ipsen Biopharmaceuticals Inc	Fremgangsmåder til behandling af en insulin-lignende vækstfaktor-I(IGF-I)-mangel
WO2005027913A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US20050261201A1 (en) *	2004-03-30	2005-11-24	Rejuvenon Corporation	Method of reducing C-reactive protein using growth hormone secretagogues
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2005272598B2 (en) *	2004-08-12	2011-11-17	Helsinn Therapeutics (U.S.), Inc.	Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2021015A2 (en) *	2006-04-28	2009-02-11	The Administrators Of The Tulane Educational Fund	Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
ES2602789T3 (es)	2007-02-09	2017-02-22	Ocera Therapeutics, Inc.	Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina
KR20090112720A (ko) *	2007-02-13	2009-10-28	헬신 세라퓨틱스 (유.에스.) 인크.	성장 호르몬 분비촉진제를 이용한 세포 증식 질환의 치료방법
TWI429436B (zh) *	2007-04-10	2014-03-11	Helsinn Therapeutics Us Inc	使用生長激素促泌素治療或預防嘔吐之方法
EP2155769B1 (en)	2007-05-04	2012-06-27	Katholieke Universiteit Leuven KU Leuven Research & Development	Tissue degeneration protection
US8466151B2 (en)	2007-12-26	2013-06-18	Critical Outcome Technologies, Inc.	Compounds and method for treatment of cancer
EP3023426A1 (en)	2008-07-17	2016-05-25	Critical Outcome Technologies, Inc.	Thiosemicarbazone inhibitor compounds and cancer treatment methods
UA105657C2 (uk)	2009-02-27	2014-06-10	Хелсінн Терапьютікс (Ю.Ес.), Інк.	Поліпшені способи лікування мігрені на основі анамореліну
US9724381B2 (en)	2009-05-12	2017-08-08	The Administrators Of The Tulane Educational Fund	Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
SG176717A1 (en)	2009-06-12	2012-01-30	Helsinn Therapeutics Us Inc	Ipamorelin diacetate injection and infusion solutions
WO2011120153A1 (en)	2010-04-01	2011-10-06	Critical Outcome Technologies Inc.	Compounds and method for treatment of hiv
WO2013190520A2 (en)	2012-06-22	2013-12-27	The General Hospital Corporation	Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en)	2014-02-05	2015-09-01	The Regents Of The University Of California	Methods of treating mild brain injury
ES2864079T3 (es)	2014-05-30	2021-10-13	Pfizer	Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
WO2017075535A1 (en)	2015-10-28	2017-05-04	Oxeia Biopharmaceuticals, Inc.	Methods of treating neurodegenerative conditions
US12012467B2 (en)	2017-03-28	2024-06-18	Regents Of The University Of Michigan	Small molecule DCN1 inhibitors and therapeutic methods using the same
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators
CN119930744B (zh) *	2025-01-20	2025-12-19	昆明理工大学	一种发酵马乳源小分子肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4223019A (en) *	1979-03-30	1980-09-16	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) *	1979-03-30	1980-10-14	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) *	1979-03-30	1980-09-16	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
WO1983002272A1 (en) *	1981-12-28	1983-07-07	Beckman Instruments Inc	Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) *	1981-12-28	1983-10-18	Beckman Instruments, Inc.	Combinations having synergistic pituitary growth hormone releasing activity
US4803261A (en) *	1986-06-27	1989-02-07	The Administrators Of The Tulane Educational Fund	Method for synthesizing a peptide containing a non-peptide
IL98910A0 (en) *	1990-07-24	1992-07-15	Polygen Holding Corp	Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en) *	1991-08-22	1997-09-02	Administrators Of The Tulane Educational Fund	Polypeptide analogues having growth hormone releasing activity
JPH08502250A (ja) *	1992-09-25	1996-03-12	スミスクライン・ビーチャム・コーポレイション	成長ホルモン放出ペプチド
WO1995014666A1 (en) *	1993-11-24	1995-06-01	Merck & Co., Inc.	Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)

1994
- 1994-12-22 CA CA002179597A patent/CA2179597A1/en not_active Abandoned
- 1994-12-22 RO RO96-01293A patent/RO115635B1/ro unknown
- 1994-12-22 AT AT95903774T patent/ATE197158T1/de not_active IP Right Cessation
- 1994-12-22 SG SG1996004604A patent/SG55069A1/en unknown
- 1994-12-22 UA UA96062486A patent/UA42747C2/uk unknown
- 1994-12-22 DK DK95903774T patent/DK0736039T3/da active
- 1994-12-22 JP JP51710995A patent/JP3181918B2/ja not_active Expired - Lifetime
- 1994-12-22 CN CN94194590A patent/CN1052731C/zh not_active Expired - Fee Related
- 1994-12-22 PT PT95903774T patent/PT736039E/pt unknown
- 1994-12-22 PL PL94315113A patent/PL181280B1/pl not_active IP Right Cessation
- 1994-12-22 KR KR1019960703336A patent/KR100354897B1/ko not_active Expired - Fee Related
- 1994-12-22 CZ CZ19961834A patent/CZ293113B6/cs not_active IP Right Cessation
- 1994-12-22 HU HU9501947A patent/HU224345B1/hu not_active IP Right Cessation
- 1994-12-22 ES ES95903774T patent/ES2153469T3/es not_active Expired - Lifetime
- 1994-12-22 US US08/448,623 patent/US5767085A/en not_active Expired - Lifetime
- 1994-12-22 AU AU12724/95A patent/AU689181B2/en not_active Ceased
- 1994-12-22 EP EP95903774A patent/EP0736039B1/en not_active Expired - Lifetime
- 1994-12-22 WO PCT/DK1994/000485 patent/WO1995017423A1/en not_active Ceased
- 1994-12-22 IL IL11211294A patent/IL112112A/xx not_active IP Right Cessation
- 1994-12-22 FI FI962584A patent/FI962584A0/fi not_active IP Right Cessation
- 1994-12-22 BR BR9408377A patent/BR9408377A/pt not_active Application Discontinuation
- 1994-12-22 SK SK820-96A patent/SK281963B6/sk unknown
- 1994-12-22 DE DE69426206T patent/DE69426206T2/de not_active Expired - Lifetime
- 1994-12-22 NZ NZ277486A patent/NZ277486A/en unknown
1995
- 1995-01-02 MX MX9500072A patent/MX9500072A/es unknown
1996
- 1996-06-21 NO NO19962665A patent/NO315561B1/no not_active IP Right Cessation
2000
- 2000-12-27 GR GR20000402838T patent/GR3035150T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH09507217A (ja)	1997-07-22
US5767085A (en)	1998-06-16
CN1052731C (zh)	2000-05-24
ATE197158T1 (de)	2000-11-15
DE69426206T2 (de)	2001-05-17
MX9500072A (es)	1997-05-31
NO962665D0 (no)	1996-06-21
SK281963B6 (sk)	2001-09-11
WO1995017423A1 (en)	1995-06-29
SG55069A1 (en)	1998-12-21
DE69426206D1 (de)	2000-11-30
EP0736039A1 (en)	1996-10-09
PL181280B1 (pl)	2001-07-31
IL112112A (en)	2000-06-29
EP0736039B1 (en)	2000-10-25
UA42747C2 (uk)	2001-11-15
HUT73497A (en)	1996-08-28
RO115635B1 (ro)	2000-04-28
PT736039E (pt)	2001-04-30
NO962665L (no)	1996-08-23
NO315561B1 (no)	2003-09-22
JP3181918B2 (ja)	2001-07-03
FI962584L (fi)	1996-06-20
ES2153469T3 (es)	2001-03-01
NZ277486A (en)	1997-03-24
HU224345B1 (hu)	2005-08-29
FI962584A7 (fi)	1996-06-20
CZ183496A3 (en)	1997-02-12
HU9501947D0 (en)	1995-11-28
GR3035150T3 (en)	2001-04-30
PL315113A1 (en)	1996-10-14
AU689181B2 (en)	1998-03-26
SK82096A3 (en)	1997-01-08
BR9408377A (pt)	1997-08-19
FI962584A0 (fi)	1996-06-20
CA2179597A1 (en)	1995-06-29
CZ293113B6 (cs)	2004-02-18
AU1272495A (en)	1995-07-10
CN1138335A (zh)	1996-12-18
KR100354897B1 (ko)	2003-01-06
IL112112A0 (en)	1995-03-15

Publication	Publication Date	Title
NO962665D0 (no)	1996-06-21	Forbindelser med veksthormonfrigjörende egenskaper
KR960701051A (ko)	1996-02-24	이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
MX9203050A (es)	1993-07-01	Compuestos de analogos de triptamina.
DK0695171T3 (da)	1997-06-02	Lyosfærer indeholdende gonadotropin
EE03262B1 (et)	2000-04-17	Imidaso[1,2-a]püridiinidest saadavad alkoksüalküülkarbamaadid, nende valmistamine ja kasutamine
DK0663835T3 (da)	1997-09-01	Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
DK0804223T3 (da)	2000-01-24	Farmaceutiske præparater indeholdende hGH
DE69307895D1 (de)	1997-03-13	Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin
BR9906975A (pt)	2000-10-17	Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero
MXPA02002007A (es)	2003-08-20	Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos.
MXPA04001977A (es)	2004-06-07	Antagonistas v de receptor ccr-3.
AU6722498A (en)	1998-09-22	Disubstituted biphenyloxazolines
GB9015774D0 (en)	1990-09-05	Novel treatment
MX9710377A (es)	1998-03-29	Compuestos con propiedades de liberacion de la hormona de crecimiento.
ATE196465T1 (de)	2000-10-15	Analoge von difluoro-staton
PL309339A1 (en)	1995-10-02	Novel triazoquinazolines, methods of obtaining them and their application
NO950114L (no)	1995-03-10	Amylin-antagonister og agonister
JO1711B1 (en)	1992-12-15	Therapeutic agents